{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:04:28Z","timestamp":1793084668634,"version":"4.5.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-HD086794"],"award-info":[{"award-number":["R01-HD086794"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>We assessed the cost-effectiveness of the Check It program, a novel community-based chlamydia screening and expedited partner treatment program for young Black men conducted in New Orleans since 2017.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We implemented a probabilistic cost-effectiveness model using a synthetic cohort of 16 181 men and 13 419 women intended to simulate the size of the Black, sexually active population in New Orleans ages 15\u201324 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The Check It program cost $196 838 (95% confidence interval [CI]: $117 320\u2013$287 555) to implement, saved 10.2 quality-adjusted life-years (QALYs; 95% CI: 7.7\u201312.7 QALYs), and saved $140 950 (95% CI: \u2212$197 018 to \u2212$105 620) in medical costs per year. The program cost $5468 (95% CI: cost saving, $16 717) per QALY gained. All iterations of the probabilistic model returned cost-effectiveness ratios less than $50 000 per QALY gained.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The Check It program (a bundled seek, test, and treat chlamydia prevention program for young Black men) is cost-effective under base case assumptions. Communities where Chlamydia trachomatis rates have not declined could consider implementing a similar program.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciab818","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T20:12:00Z","timestamp":1637611920000},"page":"2166-2172","source":"Crossref","is-referenced-by-count":4,"title":["Cost-effectiveness of Check It: A Novel Community-Based Chlamydia Screening and Expedited Treatment Program for Young Black Men"],"prefix":"10.1093","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5438-9312","authenticated-orcid":false,"given":"Charles","family":"Stoecker","sequence":"first","affiliation":[{"name":"Department of Health Policy and Management, Tulane University School of Public Health and Tropical Medicine , New Orleans, Louisiana , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Monnette","sequence":"additional","affiliation":[{"name":"McKesson Corporation , New Orleans, Louisiana , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuolin","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Mathematics, University of Texas at San Antonio , San Antonio, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norine","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine , New Orleans, Louisiana , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan Clare","family":"Craig-Kuhn","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine , New Orleans, Louisiana , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J","family":"Kissinger","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine , New Orleans, Louisiana , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"2022070618171808300_CIT0001","volume-title":"Sexually transmitted disease surveillance, 2018","author":"Centers for Disease Control and Prevention.","year":"2019"},{"key":"2022070618171808300_CIT0002","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/aje\/kwy272","article-title":"The impact of screening and partner notification on chlamydia prevalence and numbers of infections averted in the United States, 2000\u20132015: evaluation of epidemiologic trends using a pair-formation transmission model","volume":"188","author":"R\u00f6nn","year":"2019","journal-title":"Am J Epidemiol"},{"key":"2022070618171808300_CIT0003","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/sti.78.6.406","article-title":"Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies","volume":"78","author":"Honey","year":"2002","journal-title":"Sex Transm Infect"},{"key":"2022070618171808300_CIT0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14290","article-title":"Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men","volume":"14","author":"Hislop","year":"2010","journal-title":"Health Technol Assess"},{"key":"2022070618171808300_CIT0005","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/OLQ.0b013e31818b64ac","article-title":"The program cost and cost-effectiveness of screening men for chlamydia to prevent pelvic inflammatory disease in women","volume":"35","author":"Gift","year":"2008","journal-title":"Sex Transm Dis"},{"key":"2022070618171808300_CIT0006","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/OLQ.0b013e31822e9192","article-title":"The cost and cost-effectiveness of expedited partner therapy compared with standard partner referral for the treatment of chlamydia or gonorrhea","volume":"38","author":"Gift","year":"2011","journal-title":"Sex Transm Dis"},{"key":"2022070618171808300_CIT0007","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00007435-199705000-00010","article-title":"Partner notification to prevent pelvic inflammatory disease in women: cost-effectiveness of two strategies","volume":"24","author":"Howell","year":"1997","journal-title":"Sex Transm Dis"},{"key":"2022070618171808300_CIT0008","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/sextrans-2020-054873","article-title":"Assessing the costs and outcomes of control programmes for sexually transmitted infections: a systematic review of economic evaluations","volume":"97","author":"Bloch","year":"2021","journal-title":"Sex Transm Infect"},{"key":"2022070618171808300_CIT0009","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"key":"2022070618171808300_CIT0010","doi-asserted-by":"crossref","first-page":"c7250","DOI":"10.1136\/bmj.c7250","article-title":"Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study","volume":"342","author":"Turner","year":"2011","journal-title":"BMJ"},{"key":"2022070618171808300_CIT0011","doi-asserted-by":"crossref","first-page":"e1001777","DOI":"10.1371\/journal.pmed.1001777","article-title":"Uptake and population-level impact of expedited partner therapy (EPT) on Chlamydia trachomatis and Neisseria gonorrhoeae: the Washington State community-level randomized trial of EPT","volume":"12","author":"Golden","year":"2015","journal-title":"PLoS Med"},{"key":"2022070618171808300_CIT0012","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/AOG.0000000000003088","article-title":"Improving women\u2019s health and combatting sexually transmitted infections through expedited partner therapy","volume":"133","author":"Jamison","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2022070618171808300_CIT0013","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/OLQ.0000000000000197","article-title":"Predictors of index patient acceptance of expedited partner therapy for Chlamydia trachomatis infection and reasons for refusal, sexually transmitted disease clinics, New York City, 2011 to 2012","volume":"41","author":"Vaidya","year":"2014","journal-title":"Sex Transm Dis"},{"key":"2022070618171808300_CIT0014","article-title":"Check it: a community-based chlamydia seek, test, and treat program for young black men who have sex with women in New Orleans, Louisiana","author":"Schmidt","year":"2021","journal-title":"Sex Transm"},{"key":"2022070618171808300_CIT0015","first-page":"834","article-title":"Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years\u2014United States, 2007-2012","volume":"63","author":"Torrone","year":"2014","journal-title":"MMWR"},{"key":"2022070618171808300_CIT0016","doi-asserted-by":"crossref","first-page":"e040789","DOI":"10.1136\/bmjopen-2020-040789","article-title":"Effect of screening young men for Chlamydia trachomatis on the rates among women: a network modelling study for high-prevalence communities","volume":"11","author":"Qu","year":"2021","journal-title":"BMJ Open"},{"key":"2022070618171808300_CIT0017","article-title":"Impact of check it: a novel community-based chlamydia screening and expedited treatment program for young black men","author":"Stoecker","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2022070618171808300_CIT0018","volume-title":"@Risk 5.7","author":"Palisade Corporation","year":"2011"},{"key":"2022070618171808300_CIT0019","doi-asserted-by":"crossref","first-page":"e040789","DOI":"10.1136\/bmjopen-2020-040789","article-title":"The effect of screening young men for Chlamydia trachomatis on the rates among women: a network modelling study for high-prevalence communities","volume":"11","author":"Qu","year":"2020","journal-title":"BMJ Open"},{"key":"2022070618171808300_CIT0020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"2022070618171808300_CIT0021","volume-title":"Consumer price index\u2014all urban consumers","author":"Bureau of Labor Statistics","year":"2012"},{"key":"2022070618171808300_CIT0022","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/OLQ.0000000000001382","article-title":"Estimates of the prevalence and incidence of chlamydia and gonorrhea among US men and women, 2018","volume":"48","author":"Kreisel","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2022070618171808300_CIT0023","volume-title":"Time costs of administering chlamydia screening to African American","author":"Monnette","year":"2020"},{"key":"2022070618171808300_CIT0024","volume-title":"Simulation modeling using @Risk: Brooks\/Cole-Duxbury","author":"Winston","year":"2001"},{"key":"2022070618171808300_CIT0025","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness\u2013the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N Engl J Med"},{"key":"2022070618171808300_CIT0026","volume-title":"Vaccines for the 21st century: a tool for decisionmaking","author":"Stratton","year":"2001"},{"key":"2022070618171808300_CIT0027","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1097\/01.olq.0000235149.41948.fa","article-title":"The direct medical cost of epididymitis and orchitis: evidence from a study of insurance claims","volume":"33","author":"Gift","year":"2006","journal-title":"Sex Transm Dis"},{"key":"2022070618171808300_CIT0028","doi-asserted-by":"crossref","first-page":"918","DOI":"10.15585\/mmwr.mm6733a2","article-title":"Trends in human papillomavirus\u2013associated cancers\u2014United States, 1999\u20132015","volume":"67","author":"Van Dyne","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022070618171808300_CIT0029","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1016\/j.vaccine.2012.07.056","article-title":"Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States","volume":"30","author":"Chesson","year":"2012","journal-title":"Vaccine"},{"key":"2022070618171808300_CIT0030","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMsa0707052","article-title":"Health and economic implications of HPV vaccination in the United States","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"2022070618171808300_CIT0031","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/01.AOG.0000120143.50098.c7","article-title":"Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more","volume":"103","author":"Goldie","year":"2004","journal-title":"Obstet Gynecol"},{"key":"2022070618171808300_CIT0032","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajog.2004.01.043","article-title":"Diagnoses and outcomes in cervical cancer screening: a population-based study","volume":"191","author":"Insinga","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"2022070618171808300_CIT0033","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/LGT.0b013e3181ac05e9","article-title":"Incidence and costs of cervical intraepithelial neoplasia in a US commercially insured population","volume":"14","author":"Henk","year":"2010","journal-title":"J Low Genit Tract Dis"},{"key":"2022070618171808300_CIT0034","doi-asserted-by":"crossref","first-page":"500e1","DOI":"10.1016\/j.ajog.2008.03.064","article-title":"The economic burden of noncervical human papillomavirus disease in the United States","volume":"198","author":"Hu","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2022070618171808300_CIT0035","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0002-9343(00)00349-1","article-title":"Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men","volume":"108","author":"Goldie","year":"2000","journal-title":"Am J Med"},{"key":"2022070618171808300_CIT0036","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/archotol.130.11.1269","article-title":"The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data","volume":"130","author":"Lang","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2022070618171808300_CIT0037","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00128360-200307000-00007","article-title":"Cost-effectiveness of pap smear screening for vaginal cancer after total hysterectomy for benign disease","volume":"7","author":"Fetters","year":"2003","journal-title":"J Low Genit Tract Dis"},{"key":"2022070618171808300_CIT0038","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0020-7292(06)60028-3","article-title":"Carcinoma of the vulva. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Beller","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"2022070618171808300_CIT0039","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.rmed.2017.03.030","article-title":"Recurrent respiratory papillomatosis: a state-of-the-art review","volume":"126","author":"Fortes","year":"2017","journal-title":"Respir Med"},{"key":"2022070618171808300_CIT0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/313914","article-title":"Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle","volume":"31","author":"Armstrong","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2022070618171808300_CIT0041","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archotol.1995.01890120044008","article-title":"Task force on recurrent respiratory papillomas: a preliminary report","volume":"121","author":"Derkay","year":"1995","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2022070618171808300_CIT0042","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/375074","article-title":"The health and economic burden of genital warts in a aet of private health plans in the United States","volume":"36","author":"Insinga","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2022070618171808300_CIT0043","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1363\/3601104","article-title":"The estimated direct medical cost of sexually transmitted diseases among American youth, 2000","volume":"36","author":"Chesson","year":"2004","journal-title":"Perspect Sex Reprod Health"},{"key":"2022070618171808300_CIT0044","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/AOG.0b013e3181f88e72","article-title":"Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness","volume":"116","author":"Melnikow","year":"2010","journal-title":"Obstet Gynecol"},{"key":"2022070618171808300_CIT0045","first-page":"1","article-title":"United States life tables, 2018","volume":"69","author":"Arias","year":"2020","journal-title":"Natl Vital Stat Rep"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciab818\/41468162\/ciab818.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/74\/12\/2166\/44479539\/ciab818.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/74\/12\/2166\/44479539\/ciab818.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T18:44:37Z","timestamp":1657133077000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/74\/12\/2166\/6448088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,2]]},"published-print":{"date-parts":[[2022,7,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab818","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,15]]},"published":{"date-parts":[[2021,12,2]]}}}